Cranial neural crest cells (CNC) are a transient population of "stem cells" that originate at the border of the neural plate and the epidermis and migrate ventrally to contribute to most of the facial structures including bones, cartilage, muscles and ganglia. ADAM13 is a cell surface metalloprotease that is essential for CNC migration. Here we show that a Wnt receptor, Fz4, binds to the cysteine rich domain of ADAM13 and negatively regulate its proteolytic activity in vivo. Gain of Fz4 function inhibit CNC migration and can be rescued by gain of ADAM13 function. Loss of Fz4 function also inhibits CNC migration and induces a reduction of mature ADAM13 together with an increase in the ADAM13 cytoplasmic fragment that is known to translocate in the nucleus to regulate gene expression. We propose that Fz4 associate with ADAM13 during transport to the plasma membrane to regulate its proteolytic activity.
INTRODUCTION
The cranial neural crest (CNC) is a stem cell population that gives rise to the craniofacial structures. Normal craniofacial development depends on the proper induction, migration, and differentiation of these cells. Wnt signaling pathways play critical roles at multiple levels during CNC development. While the canonical Wnt/-catenin pathway is known to mediate CNC induction (Stuhlmiller and Garcia-Castro, 2012) , the non-canonical Wnt/PCP (planar cell polarity) pathway is implicated in CNC cell migration (Mayor and Theveneau, 2014) . In contrast, in the mouse, KO of Vangl2, one of the PCP components, does not affect neural crest migration, suggesting that the Wnt/PCP signaling is not critical for neural crest cell migration in increasing Notch signaling (Esteve et al., 2011) . In Xenopus, at least three ADAMs, ADAM9,experiments, we found that the Cysteine-rich domain of ADAM13 was sufficient to promote 94 Fz4-v1 interaction, while the Disintegrin domain could not (Fig. 1B) . Interestingly this domain 95 of ADAM13 is also responsible for interacting with the second heparin-binding domain of 96 fibronectin (Gaultier et al., 2002) and is thought to control proteolytic specificity (Smith et al., 97 2002) . 98
While the functional analyses showing that Fz4/Fz4-v1 KD inhibits CNC migration 99 strongly suggest that these proteins are present in the CNC (Gorny et al., 2013) , the published 100 expression pattern reported for Fz4 and Fz4-v1 (Shi and Boucaut, 2000) do not closely match 101 neural crest cells, suggesting that Fz4/Fz4-v1 could act on the CNC from adjacent tissues (for 102 example, the placodes). To confirm that either of these mRNA is present we performed 103 quantitative realtime PCR with dissected CNC explants using primers designed to selectively 104 amplify each form. The result shows that both forms are indeed expressed in the CNC (CT 28 105 and 29 respectively), but these mRNA are not restricted to these cells, confirming the in situ 106 hybridization (ISH) pattern. When compared to Slug, a typical CNC marker, the overall 107 expression levels of Fz4 and Fz4-v1 in whole embryos at stage 17 are very similar and represent 108 between 2 (Fz4-v1) and 4 (Slug, Fz4) percent of GAPDH expression. At the same stage, in the 109 CNC Slug is expressed at 57 percent of the GAPDH level, making it very obvious by ISH. On 110 the other hand, Fz4 and Fz4-v1 are expressed at 5 and 2 percent of GAPDH, respectively, a level 111 similar to the global expression in the embryo. We also performed double ISH using a Fz4-112 receptor specific full length probe and a short LNA-probe which is specific for Fz4-v1, but not 113 Fz4 (Gorny et al., 2013) to distinguish between the two Fz4 splice variants ( Fig. 1D and Fig. S1 , 114 blue) and the neural crest markers Sox10 and Twist (red). With this technique it is clear that v1 is present in the CNC at both stage 20 and stage 24, while Fz4 appears to be expressed in 116 placodes as well as the extreme tips of the CNC segments (arrowhead). Together these data show 117 that ADAM13, Fz4 and Fz4-v1 are all expressed in the CNC and that ADAM13 and Fz4-v1 118 expression patterns clearly overlap. 119
To determine if ADAM13 colocalizes with either form of Fz4, in the absence of 120 antibodies to Fz4, we fused ADAM13 to a C-terminal GFP and Fz4 and Fz4-v1 with C-terminal 121 RFP and co-expressed these constructs in Xenopus CNC and cell lines ( Fig. 2 and Fig. S2 ). In 122 the CNC, Fz4 is detected in two main compartments, vesicles and the plasma membrane 123 associated with the fibronectin substrate (Fig. 2, supplemental movie 1 ). ADAM13 protein isdetected in all membranes but enriched in cellular protrusions in contact with the fibronectin 125 substrate as well as in vesicles. ADAM13 colocalizes with Fz4 in a subset of vesicles (Fig. 2  126 upper and middle panel, arrowheads) and at the membrane in contact with the substrates (Fig. 2  127 middle panel, arrows). The localization of Fz4-v1 is clearly distinct, surrounding the nucleus in a 128 pattern resembling the endoplasmic reticulum. In time-lapse movies at the level of the substrate, 129
Fz4-v1 appears to be closely associated with ADAM13 in some membrane protrusions (Fig. 2  130 lower panel, rectangle, and supplemental movie 2). Thus, the subcellular localization of 131 ADAM13, Fz4 and Fz4-v1 is compatible with a potential interaction of these proteins in the 132 migrating CNC. 133
In Xenopus XTC cells we used sub cellular markers to identify the compartment in which 134 ADAM13 co-localizes with Fz4 and Fz4-v1. Fz4 expression overlaps with both the ER-and 135
Lyso-tracker in XTC cells (Fig. S2) , while there is almost no-overlap with Wheat-germ 136 agglutinin (WGA), a Golgi marker (Fig. S2) . ADAM13 was detected associated with all three 137 markers but appeared to only colocalize with Fz4 in the ER in these cells (Fig. S2 ). The vesicles 138 in which ADAM13 and Fz4 colocalized did not stain with any of the marker tested, suggesting 139 that there were neither Golgi nor Lysosomal in origin. The staining obtained for Fz4-v1 was 140 much more obvious and appeared to be restricted to the ER where it perfectly co-localized with 141 ADAM13 (Fig. S2) . Again, in WGA-positive vesicles ADAM13 appeared to be mostly free of 142 Fz4-v1 suggesting that the protein do not transit to the cell surface together in XTC cells (Fig.  143   S2 ). Unfortunately these markers could not be used in CNC explant as they all bound very 144 strongly to the yolk rich platelets (data not shown). A similar distribution of ADAM13-GFP, 145
Fz4-RFP, Fz4-v1-RFP was also found in transfected U2OS (human osteosarcoma cell line) cells 146 using Calnexin and GM130 antibodies to identify the ER and Golgie respectively (data not 147 shown). 148
149

Fz4 inhibits ADAM13 proteolytic activity and CNC migration. 150
Having established that all three mRNA are expressed in the CNC and that upon 151 expression of fluorescent forms of the protein, they are expressed in overlapping compartments 152 in the CNC, we next tested whether the interaction between Fz4 and ADAM13 affects its 153 proteolytic activity. We tested the ability of Fz4 and Fz4-v1 to inhibit ADAM13 cleavage of the 154 paraxial protocadherin (PAPC) (Fig. 3A, Shed PAPC) . In this experiment, we found that the fulllength Fz4 was more efficient (≈100% inhibition) than the secreted Fz4-v1 (≈50% inhibition) at 156 inhibiting ADAM13 cleavage of PAPC. On the other hand, neither form effectively prevented 157 self-shedding of ADAM13 (Fig. 3A, Shed A13 ). We also found that Fz4-v1 was able to inhibit 158 ADAM13 cleavage of Cadherin-11 in HEK-293T cells (Fig. S3) Cadherin-11 (EC1-3). Interestingly while ADAM13 and EC1-3 were capable of partially 172 rescuing both forms of Fz4 overexpressed, the rescue of the full length Fz4 was much more 173 efficient in our assay than that of the secreted Fz4-v1 ( Fig. 4A and B) . 174
To test if the secreted Fz4-v1 inhibited migration in a cell autonomous manner we 175 performed grafts of CNC expressing Fz4-v1 into wild type embryos, as well as wild type CNC 176 into Fz4-v1 expressing embryos (Fig. 4C) . Our results show that CNC migration is only inhibited 177 when Fz4-v1 is expressed by the CNC. Similarly, we found that mixing cells expressing Fz4-v1 178 with cells expressing ADAM13 and PAPC did not inhibit PAPC shedding, suggesting that the 179 secreted Fz4-v1 was unable to inhibit ADAM13 proteolytic activity on adjacent cells (Fig. 4D) . 180
This result, taken together with the data showing colocalization of ADAM13 with Fz4 and Fz4-181 v1 in mostly internal compartments ( Fig. 2 and Fig. S2 ), and the CoIP with the Pro-form of 182 ADAM13 (Fig. 1B) , suggests that the functional interaction is occurring during the transit of 183 ADAM13 to the cell surface. Another possibility is that PAPC may already be cleaved prior to 184 both proteins (ADAM13 and PAPC) reaching the surface. 185
Loss of Fz4 inhibits CNC migration and increases ADAM13 processing. 187
Our results suggest that both forms of Fz4 can interact with ADAM13 and inhibit its 188 proteolytic activity. To test if this was important in vivo we performed loss-of-function 189 experiments by knocking down Fz4 (and Fz4-v1). As previously reported (Gorny et al., 2013), 190 Fz4 morpholino (MOFz4) inhibits CNC migration both in grafting experiments (Fig. 5A-B, and  191 supplemental movie 3) and targeted injection (Fig. 5C ). In targeted injections we found that we 192 could not rescue CNC migration in embryos lacking Fz4 by overexpressing ADAM13 (Fig. 5C) . These results suggest that expression of ADAM13 should be able to alleviate part of the 213 Fz4 KD phenotype by at least providing a larger pool of ADAM13 protein during the onset of 214 CNC migration. To test this hypothesis in more detail, we used in situ hybridization with CNC 215 markers (Sox10 and Twist) to visualize the position of the CNC toward the end of migration 216 (Fig. 7) . As seen for both graft and targeted injections we found that the loss of Fz4 significantlyaffected the position of the CNC (Fig. 5 ). While targeted injections were scored by counting the 218 number of embryos that had no visible fluorescent cells in the CNC pathway, the in situ 219 hybridization were scored for the relative length of the segments (inhibited weak or strong), as 220 well as the position and the separation of each segment (fused). Using this latter assay, we found 221 that ADAM13 overexpression was indeed capable of reducing the severity of the CNC defects in 222 embryos lacking Fz4 (Fig. 7) . Accordingly, the recombinant cleavage fragment of Cadherin-11 223 by ADAM13, EC1-3 was also capable of restoring the quality of CNC migration. This was true 224 when the injections were done into both of the left or right cells at the 4-cell stage (Fig. 7A) or 225 when targeted to one dorsal animal blastomere at the 8-cell stage (Fig. 7B) . 226
Together these data support the model by which one of the roles of Fz4 or Fz4-v1 during 227 CNC migration is to regulate the proteolytic activity of ADAM13. protease at the cell surface (100 kDa) and the cytoplasmic fragment within the nucleus (17 kDa). 236
While we know that both forms are essential, it remains unclear how and when the cytoplasmic 237 fragment is generated. We know that cleavage by gamma-secretase releases the cytoplasmic 238 domain from the membrane and that this follows an initial cleavage within the Cysteine-rich 239 domain by ADAM13 itself (Cousin et al., 2011). Loss of Fz4 appears to increase the rate or 240 induce precocious processing of ADAM13, while overexpression reduces this processing (Fig.  241 6). In cell culture, transfected Fz4 associates preferentially with the Pro-form of ADAM13 and 242 appears to co-localize with ADAM13 in the ER, vesicles and at the plasma membrane ( In addition, loss of Fz4 inhibits CNC migration. Our targeted injections suggest that ADAM13 267 cannot rescue CNC migration in embryos missing Fz4. This suggests that Fz4 is involved in 268 multiple other roles in the CNC that remain to be investigated. On the other hand, the in situ 269 hybridization data (Fig. 7) suggest that the Fz4 KD phenotype can be partially rescued by 270 ADAM13 or the EC1-3 fragment of Cadherin-11, which mimics the cleavage by ADAM13. to ADAM13. Fz4 is the most efficient at inhibiting ADAM13 activity but also reduces the 302 ADAM13 protein level (Fig. 3 and 6 ). This may explain why this form of overexpression is 303 rescued the most efficiently by expressing additional ADAM13 or the Cadherin-11 EC1-3 304 fragment. On the other hand, Fz4-v1 overexpression has little effect on mature ADAM13 levels 305 but does significantly reduce the processing of the ADAM13 cytoplasmic domain (Fig. 6B) . The 306 results obtained for Fz4 KD, showing an increase in the cytoplasmic domain fragment of 307 ADAM13, suggest that the main form associated with ADAM13 in the CNC is Fz4-v1 at least at 308 stage 24. This is also consistent with the Fz4-v1 expression pattern and the fact that Fz4-v1 can 309 rescue CNC migration in Fz4 morphant embryos. The expression pattern of Fz4 shows that itincreases at the edges of the migration path toward the end of their progression (Fig. 1D and Fig.  311   S1 ). This increase could block ADAM13 proteolytic activity so that cadherins and other cell- It is unclear at the moment whether Fz4 binding to a Wnt ligand increases, decreases or has no 333 effect on its ability to inhibit ADAM13. In addition, it is also unclear if ADAM13 binding to Fz4 334 modifies its ability to respond to Wnt and signal. In Xenopus tropicalis, loss of ADAM13 results 335 in a severe decrease in Wnt signaling during neural crest cell induction (Wei et al., 2010) . This is 336 attributed to a loss of cleavage of ephrinB, resulting in an abnormal accumulation and increased 337 signaling that in turns decreases canonical Wnt signaling. In Xenopus laevis, while the KD of 338 ADAM13 also increases ephrinB protein levels, there is no effect on Wnt signaling. In contrast, 339 KD of the two paralogues (ADAM13 and MDC13) does result in a significant decrease in β-340 catenin levels during gastrulation (Alfandari et al., unpublished). In this model, however, it isunclear if this change is due to ephrinB cleavage or a more direct effect on the Wnt pathway. 342
These new results showing a direct physical interaction with Fz receptor, suggest a more direct 343 role of ADAM13 in regulating the Wnt pathway, a role that will require further investigation. 344
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